Stocktoria
Can B Corp NASC
OTC · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · LEI
Can B Corp financials (annual)
Bars are annual figures from 2015 to 2023; red bars are negative (a loss or cash outflow).
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2M | $6.7M | $4.6M | $1.7M | $2.3M | $668,603 | $122,746 | $95,145 | $110,431 |
| Gross profit | $358,698 | $2.6M | $3.0M | $1.4M | $1.7M | $263,069 | $78,280 | — | — |
| R&D expense | — | — | — | $165,000 | $150,000 | $75,000 | $37,000 | — | — |
| SG&A expense | — | $926,696 | $675,310 | — | — | — | — | — | — |
| Operating income | -$7.5M | -$14.2M | -$10.3M | -$7.5M | -$5.9M | -$3.4M | -$712,786 | — | — |
| Interest expense | $2.5M | $902,130 | $2.1M | $934,683 | $8,793 | $263,510 | $279,221 | -$56,234 | -$48,666 |
| Income tax | $9,596 | $793 | $1,075 | $3,304 | $2,084 | — | -$748,902 | -$232,768 | -$1.3M |
| Net income | -$9.7M | -$14.9M | -$12.2M | -$8.9M | -$5.9M | -$4.1M | -$2.1M | -$665,050 | -$3.6M |
| EPS (diluted) | $-0.77 | $-4.18 | — | $-1.36 | $-2.20 | — | — | — | — |
| Operating cash flow | -$1.3M | -$3.9M | -$7.5M | -$1.9M | -$2.4M | -$753,569 | -$286,291 | -$142,430 | -$337,415 |
| Free cash flow | -$1.3M | — | -$8.0M | -$2.0M | -$3.5M | -$799,953 | — | — | — |
| Cash & equivalents | $34,006 | $73,194 | $449,001 | $457,798 | $46,540 | $807,747 | $1,652 | $30,193 | $18,373 |
| Inventory | $1.6M | $2.0M | $2.6M | $344,954 | $784,497 | $87,104 | $9,834 | — | — |
| Total assets | $10.1M | $15.6M | $16.5M | $3.9M | $7.2M | $3.7M | $219,307 | $136,978 | $180,301 |
| Total liabilities | $12.0M | $12.9M | $10.9M | $2.4M | $564,666 | $204,792 | $1.9M | — | — |
| Shareholders' equity | -$1.9M | $2.7M | $5.6M | $1.5M | $6.6M | $3.5M | -$1.7M | -$514,588 | $103,288 |
Growth · year-over-year · Revenue CAGR 45%
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -67.8% | +45.2% | +169.3% | -25.8% | +244.8% | +444.7% | +29.0% | -13.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2023-12-31. Facts plus Stocktoria's own computed scores — not investment advice.